Post-Menopause Skin Rejuvenation Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 14, 2025

Primary Completion Date

August 28, 2026

Study Completion Date

September 28, 2026

Conditions
AestheticMenopausePost-menopauseInjectablesBiostimulatorHyaluronic Acid
Interventions
DEVICE

Restylane SkinBoosters Vital

"Restylane® Skinboosters™ Vital (HASBV) is manufactured by Galderma Laboratories. It is a sterile non-animal hyaluronic acid (20mg/mL) based gel that is supplied in a 1mL glass syringe. The syringed is packed with a 29G TW (thin-walled) needle.~For this study, commercial products will be used. The study products are for single use only."

DRUG

Sculptra Aesthetic

"Sculptra® Aesthetic (PLLA-SCA) is manufactured by Galderma Laboratories. It is a sterile, lyophilized preparation of PLLA that is biocompatible and biodegradable. Each vial contains 367.5 mg of freeze-dried powder, including 150 mg of PLLA. Prior to injection, it will be reconstituted with sterile water for injection (SWFI) and lidocaine hydrochloride (2%).~For this study, commercial products will be used. The study products are for single use only."

Trial Locations (1)

H3Z 1C3

RECRUITING

Erevna Innovations Inc., Montreal

Sponsors
All Listed Sponsors
lead

Erevna Innovations Inc.

OTHER

NCT07205744 - Post-Menopause Skin Rejuvenation Study | Biotech Hunter | Biotech Hunter